Safety and Efficacy of VAY736 in Patients With Primary Sjogren's Syndrome (pSS)
Clinical trial NCT02962895 · COMPLETED
Trial details
- NCT number
- NCT02962895
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-27
- Primary completion
- 2020-06-30
- Enrollment
- 190
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.